MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

[1]  Danish Sayed,et al.  MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. , 2008, Molecular biology of the cell.

[2]  Chaoqian Xu,et al.  The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 , 2011, Nature Medicine.

[3]  T. Golub,et al.  MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia , 2007, Proceedings of the National Academy of Sciences.

[4]  Jialing Huang,et al.  Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes , 2007, Nature Medicine.

[5]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[6]  Jian-Fu Chen,et al.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. , 2007, Journal of molecular and cellular cardiology.

[7]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[8]  Xiaoxia Qi,et al.  Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.

[9]  Michael T. McManus,et al.  Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.

[10]  Chunxiang Zhang,et al.  MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? , 2007, The American journal of pathology.

[11]  Thomas Thum,et al.  MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure , 2007, Circulation.

[12]  M. Lohse,et al.  A Role for Caspase-1 in Heart Failure , 2007, Circulation research.

[13]  Danish Sayed,et al.  MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy , 2007, Circulation research.

[14]  Vladimir Benes,et al.  A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). , 2006, RNA.

[15]  P. Stern,et al.  In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes , 2006, Nature Genetics.

[16]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[17]  A. McMahon,et al.  Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. , 2005, Developmental cell.

[18]  K. Lorenz,et al.  The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy , 2004, Nature Medicine.

[19]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[20]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[21]  T. Thum,et al.  Mechanistic Role of Cytochrome P450 Monooxygenases in Oxidized Low-Density Lipoprotein–Induced Vascular Injury: Therapy Through LOX-1 Receptor Antagonism? , 2004, Circulation research.

[22]  E. Nishida,et al.  Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway , 2002, Nature Cell Biology.

[23]  M. Lohse,et al.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Matthew Freeman,et al.  Sprouty, an Intracellular Inhibitor of Ras Signaling , 1999, Cell.

[25]  T. Lufkin,et al.  Dicistronic LacZ and alkaline phosphatase reporter constructs permit simultaneous histological analysis of expression from multiple transgenes. , 1997, BioTechniques.

[26]  S. Vatner,et al.  Effects of chronic beta-adrenergic receptor stimulation in mice. , 1997, Journal of molecular and cellular cardiology.

[27]  G. Martin,et al.  Analysis of Fgf8 gene function in vertebrate development. , 1997, Cold Spring Harbor symposia on quantitative biology.

[28]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Pouysségur,et al.  Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Ross,et al.  Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy , 1991, Proceedings of the National Academy of Sciences of the United States of America.